Epilepsy and disease modification: Animal models for novel drug discovery

Epilepsy: Mechanisms, Models, and Translational Perspectives

Volumn , Issue , 2010, Pages 143-158

  Steve White, H ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883645692     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420085594     Document Type: Chapter

References (83)

1. Armand, V., C. Rundfeldt, U. Heinemann. (2000). Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices. Epilepsia, 41:28-33.
2. Avanzini, G.G., D.M. Treiman, J. Engel. (2008). Animal models of acquired epilepsies and status epilepticus. In Epilepsy: A Comprehensive Textbook (pp. 415-444), J. Engel, T.A. Pedley, J. Aicardi, M.A. Dichter, and S. Moshé, Eds. Philadelphia, PA: Lippincott Williams & Wilkins.
3. Baram, T.Z., A. Gerth, L. Schultz. (1997). Febrile seizures: an appropriate-aged model suitable for long-term studies. Brain Res. Dev. Brain Res., 98:265-270.
4. Barton, M.E., B.D. Klein, H.H. Wolf, H.S. White. (2001). Pharmacological characterization of the 6-Hz psychomotor seizure model of partial epilepsy. Epilepsy Res., 47:217-227.
5. Ben-Ari, Y., J. Lagowska, E. Tremblay, G. Le Gal La Salle. (1979). A new model of focal status epilepticus:intra-amygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures. Brain Res., 163:176-179.
6. Ben-Ari, Y., E. Tremblay, O.P. Ottersen. (1980). Injections of kainic acid into the amygdaloid complex of the rat:an electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience, 5:515-528.
7. Bender, R.A., C. Dube, T.Z. Baram. (2004). Febrile seizures and mechanisms of epileptogenesis: insights from an animal model. Adv. Exp. Med. Biol., 548:213-225.
8. Bialer, M., S.I. Johannessen, H.J. Kupferberg, R.H. Levy, E. Perucca, T. Tomson. (2007). Progress report on new antiepileptic drugs: a summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res., 73(1):1-52.
9. Bialer, M., S.I. Johannessen, R.H. Levy, E. Perucca, T. Tomson, H.S. White. (2009). Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (Eilat IX). Epilepsy Res., 83(1):1-43.
10. Blumenfeld, H., J.P. Klein, U. Schridde, M. Vestal, T. Rice et al. (2008). Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia, 49:400-409.
11. Brandt, C., H.A. Volk, W. Löscher. (2004). Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia, 45:1488-1497.
12. Brown, W.C., D.O. Schiffman, E.A. Swinyard, L.S. Goodman. (1953). Comparative assay of antiepileptic drugs by psychomotor seizure test and minimal electroshock threshold test. J. Pharmacol. Exp. Ther., 107:273-283.
13. Bush, P.C., D.A. Prince, K.D. Miller. (1999). Increased pyramidal excitability and NMDA conductance can explain posttraumatic epileptogenesis without disinhibition: a model. J. Neurophysiol., 82:1748-1758.
14. Chen, K., A. Neu, A.L. Howard, C. Foldy, J. Echegoyen, L. Hilgenberg, M. Smith, K. Mackie, I. Soltesz. (2007). Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci., 27:46-58.
15. Coenen, A.M., E.L. Van Luijtelaar. (2003). Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav. Genet., 33:635-655.
16. Dichter, M.A., J. Pollared. (2006). Cell culture models for studying epilepsy. In Models of Seizures and Epilepsy (pp. 23-34), A. Pitkanen, P.A. Schwartzkroin, and S.L. Moshe, Eds. New York: Elsevier.
17. Dudek, F.E. (2009). Commentary: a skeptical view of experimental gene therapy to block epileptogenesis. Neurotherapeutics, 6:319-322.
18. Echlin, F.A., A. Battista. (1963). Epileptiform seizures from chronic isolated cortex. Arch. Neurol., 9:154-170.
19. Everett, G.M., R.K. Richards. (1944). Comparative anticonvulsive action of 3,5,5-trimethyloxazolidine-2,4- dione (tridione), dilantin, and phenobarbital. J. Pharmacol. Exp. Ther., 81(4):402-407.
20. Glien, M., C. Brandt, H. Potschka, W. Löscher. (2002). Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy. Epilepsia, 43:350-357.
21. Goddard, G.V., D.C. McIntyre, C.K. Leech. (1969). A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol., 25:295-330.
22. Gower, A.J., M. Noyer, R. Verloes, J. Gobert, E. Wulfert. (1992). UCB l059, a novel anti-convulsant drug:pharmacological profile in animals. Eur. J. Pharmacol., 222:193-203.
23. Gower, A.J., E. Hirsch, A. Boehrer, M. Noyer, C. Marescaux. (1995). Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res., 22:207-213.
24. Grabenstatter, H.L., F.E. Dudek. (2005). The effect of carbamazepine on spontaneous seizures in freely-behaving rats with kainite-induced epilepsy. Epilepsia, 46(Suppl. 8):287.
25. Grabenstatter, H.L., D.J. Ferraro, P.A. Williams, P.L. Chapman, F.E. Dudek. (2005). Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia, 46:8-14.
26. Heinemann, U., O. Kann, S. Schuchmann. (2006). An overview of in vitro seizure models in acute and organotypic slices. In Models of Seizures and Epilepsy (pp. 35-44), A. Pitkanen, P.A. Schwartzkroin, and S.L. Moshe, Eds. New York: Elsevier.
27. Hellier, J.L., P.R. Patrylo, P.S. Buckmaster, F.E. Dudek. (1998). Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res., 31:73-84.
28. Hosford, D.A., Y. Wang. (1997). Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia, 38:408-414.
29. Hosford, D.A., S. Clark, Z. Cao, W.A. Wilson, Jr., F.H. Lin, R.A. Morrisett, A. Huin. (1992). The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science, 257:398-401.
30. Jefferys, J.G. (1996). Chronic epileptic foci induced by intracranial tetanus toxin. Epilepsy Res. Suppl., 12:111-117.
31. Jefferys, J.G., B.J. Evans, S.A. Hughes, S.F. Williams. (1992). Neuropathology of the chronic epileptic syndrome induced by intrahippocampal tetanus toxin in rat: preservation of pyramidal cells and incidence of dark cells. Neuropathol. Appl. Neurobiol., 18:53-70.
32. Jensen, F.E. (1995). An animal model of hypoxia-induced perinatal seizures. Ital. J. Neurol. Sci., 16:59-68.
33. Jiang, M., C.L. Lee, K.L. Smith, J.W. Swann. (1998). Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J. Neurosci., 18:8356-8368.
34. Kadam, S.D., F.E. Dudek. (2007). Neuropathogical features of a rat model for perinatal hypoxic-ischemic encephalopathy with associated epilepsy. J. Comp. Neurol., 505:716-737.
35. Klitgaard, H., A. Matagne, J. Gobert, E. Wulfert. (1998). Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur. J. Pharmacol., 353:191-206.
36. Kupferberg, H. (2001). Animal models used in the screening of antiepileptic drugs. Epilepsia, 42(Suppl. 4):7-12.
37. Leite, J.P., E.A. Cavalheiro. (1995). Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res., 20:93-104.
38. Lennox, W.G. (1945). The petit mal epilepsies: their treatment with Tridone. JAMA, 129:1069-1074.
39. Libbey, J.E., N.J. Kirkman, M.C. Smith, T. Tanaka, K.S. Wilcox, H.S. White, R.S. Fujinami. (2008). Seizures following picornavirus infection. Epilepsia, 49:1066-1074.
40. Löscher, W. (2002). Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res., 50:105-123.
41. Löscher, W., D. Honack. (1991). Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol. Sci., 12:52.
42. Löscher, W., D. Honack. (1993). Profile of ucb l059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur. J. Pharmacol., 232:147-158.
43. Löscher, W., D. Honack, C. Rundfeldt. (1998). Antiepileptogenic effects of the novel anticonvulsant levetiracetam (UCB l059) in the kindling model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther., 284:474-479.
44. Löscher, W., E. Reissmuller, U. Ebert. (2000). Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin- resistant kindled rats. Epilepsy Res., 40:63-77.
45. Marescaux, C., M. Vergnes. (1995). Genetic absence epilepsy in rats from Strasbourg (GAERS). Ital. J. Neurol. Sci., 16:113-118.
46. Meldrum, B.S. (1995). Neurotransmission in epilepsy. Epilepsia, 36:S30-S35.
47. Nissinen, J., T. Halonen, E. Koivisto, A. Pitkanen. (2000). A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat. Epilepsy Res., 38:177-205.
48. Noebels, J.L., D.M. Treiman, J. Engel. (2008). Genetic models of epilepsy. In Epilepsy: A Comprehensive Textbook (pp. 445-455), J. Engel, T.A. Pedley, J. Aicardi, M.A. Dichter, and S. Moshé, Eds. Philadelphia, PA: Lippincott Williams & Wilkins.
49. Pitkanen, A., T.P. Sutula. (2002). Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol., 1:173-181.
50. Pitkanen, A., S. Narkilahti, Z. Bezvenyuk, A. Haapalinna, J. Nissinen. (2004). Atipamezole, an alpha(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res., 61:119-140.
51. Pitkanen, A., R.J. Immonen, O.H. Grohn, I. Kharatishvili. (2009). From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Epilepsia, 50(Suppl. 2):21-29.
52. Postma, T., E. Krupp, X.L. Li, R.M. Post, S.R. Weiss. (2000). Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy. Epilepsia, 41:1514-1521.
53. Prince, D.A., K. Jacobs. (1998). Inhibitory function in two models of chronic epileptogenesis. Epilepsy Res., 32:83-92.
54. Putnam, T.J., H.H. Merritt. (1937). Experimental determination of the anticonvulsant properties of some phenyl derivatives. Science, 85:525-526.
55. Sarkisian, M.R. (2001). Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav., 2:201-216.
56. Sharpless, S.K., L.M. Halpern. (1962). The electrical excitability of chronically isolated cortex studied by means of permanently implanted electrodes. Electroencephalogr. Clin. Neurophysiol., 14:244-255.
57. Singh, N.A., J.F. Otto, E.J. Dahle, C. Pappas, J.D. Leslie, A. Vilaythong, J.L. Noebels, H.S. White, K.S. Wilcox, M.F. Leppert. (2008). Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J. Physiol., 586:3405-3423.
58. Smyth, M.D., N.M. Barbaro, S.C. Baraban. (2002). Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia. Epilepsy Res., 50:251-264.
59. Snead, O.C., 3rd. (1992). Pharmacological models of generalized absence seizures in rodents. J. Neural Transm., 35(Suppl.):7-19.
60. Srivastava, A., H.S. White. (2005). Retigabine decreases behavioral and electrographic seizures in the lamotrigineresistant amygdale kindled rat model of pharmacoresistant epilepsy. Epilepsia, 46(Suppl. 8):217-218.
61. Srivastava, A., J.H. Woodhead, H.S. White. (2003). Effect of lamotrigine, carbamazepine and sodium valproate on lamotrigine-resistant kindled rats. Epilepsia, 44(Suppl. 9):42.
62. Srivastava, A., M.R. Franklin, B.S. Palmer, H.S. White. (2004). Carbamazepine, but not valproate, displays pharmaco-resistance in lamotrigine-resistant amygdala kindled rats. Epilepsia, 45(Suppl. 7):12.
63. Stables, J.P., E.H. Bertram, H.S. White, D.A. Coulter, M.A. Dichter, M.P. Jacobs, W. Löscher, D.H. Lowenstein, S.L. Moshe, J.L. Noebels, M. Davis. (2002). Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia, 43:1410-1420.
64. Stables, J.P., E. Bertram, F.E. Dudek, G. Holmes, G. Mathern, A. Pitkanen, H.S. White. (2003). Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES Models II workshop. Epilepsia, 44:1472-1478.
65. Stafstrom, C.E., T.P. Sutula. (2005). Models of epilepsy in the developing and adult brain: implications for neuroprotection. Epilepsy Behav., 7(Suppl. 3):S18-S24.
66. Sutula, T., C. Harrison, O. Steward. (1986). Chronic epileptogenesis induced by kindling of the entorhinal cortex: the role of the dentate gyrus. Brain Res., 385:291-299.
67. Sutula, T., X.X. He, J. Cavazos, G. Scott. (1988). Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science, 239:1147-1150.
68. Swinyard, E.A. (1972). Electrically induced convulsions. In Experimental Models of Epilepsy (pp. 443-458), D.B. Purpura, J.K. Penry, D. Tower, D.M. Woodbury, and R. Walter, Eds. New York: Raven Press.
69. Toman, J.E. (1951). Neuropharmacologic considerations in psychic seizures. Neurology, 1:444-460.
70. Toman, J.E., G.M. Everett, R.K. Richards. (1952). The search for new drugs against epilepsy. Tex. Rep. Biol. Med., 10:96-104.
71. Turski, L., E.A. Cavalheiro, S.J. Czuczwar, W.A. Turski, Z. Kleinrok. (1987). The seizures induced by pilocarpine:behavioral, electroencephalographic and neuropathological studies in rodents. Pol. J. Pharmacol. Pharm., 39:545-555.
72. Turski, L., C. Ikonomidou, W.A. Turski, Z.A. Bortolotto, E.A. Cavalheiro. (1989). Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse, 3:154-171.
73. van Vliet, E.A., R. van Schaik, P.M. Edelbroek, S. Redeker, E. Aronica, W.J. Wadman, N. Marchi, A. Vezzani, J.A. Gorter. (2006). Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia, 47:672-680.
74. Weiss, S.R., R.M. Post. (1991). Development and reversal of contingent inefficacy and tolerance to the anticonvulsant effects of carbamazepine. Epilepsia, 32:140-145.
75. White, H.S. (1997). Mechanisms of antiepileptic drugs. In Epilepsies II (pp. 1-30), R. Porter and D. Chadwick, Eds. Boston, MA: Butterworth-Heinemann.
76. White, H.S., J.H. Woodhead, M.R. Franklin, E.A. Swinyard, H.H. Wolf. (1995a). General principles: experimental selection, quantification, and evaluation of antiepileptic drugs. In Antiepileptic Drugs, 4th ed. (pp. 99-110), R.H. Levy, R.H. Mattson, and B.S. Meldrum, Eds. New York: Raven Press.
77. White, H.S., M. Johnson, H.H. Wolf, H.J. Kupferberg. (1995b). The early identification of anticonvulsant activity:role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital. J. Neurol. Sci., 16:73-77.
78. White, H.S., J.H. Woodhead, K.S. Wilcox, J.P. Stables, H.J. Kupferberg, H.H. Wolf. (2002). Discovery and preclinical development of antiepileptic drugs. In Antiepileptic Drugs (pp. 36-48), R.H. Levy, R.H. Mattson, B. Meldrum, and E. Perucca, Eds. Philadelphia, PA: Lippincott Williams & Wilkins.
79. White, H.S., A. Srivastava, B. Klein, B. Zhao, Y. Moon Choi, R. Gordon, S.J. Lee. (2006). The novel investigational neuromodulator RWJ 333369 displays a broad-spectrum anticonvulsant profile in rodent seizure and epilepsy models. Epilepsia, 47(Suppl. 4):200.
80. Williams, P.A., F.E. Dudek. (2007). A chronic histopathological and electrophysiological analysis of a rodent hypoxic-ischemic brain injury model and its use as a model of epilepsy. Neuroscience, 149:943-961.
81. Williams, P.A., P. Dou, F.E. Dudek. (2004). Epilepsy and synaptic reorganization in a perinatal rat model of hypoxia-ischemia. Epilepsia, 45:1210-1218.
82. Willmore, L.J., G.W. Sypert, J.V. Munson, R.W. Hurd. (1978). Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science, 200:1501-1503.
83. Yu, F.H., M. Mantegazza, R.E. Westenbroek, C.A. Robbins, F. Kalume, K.A. Burton, W.J. Spain, G.S. McKnight, T. Scheuer, W.A. Catterall. (2006). Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat. Neurosci., 9:1142-1149.